Research Analysts Set Expectations for NTLA FY2025 Earnings
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) – Analysts at Cantor Fitzgerald lifted their FY2025 earnings estimates for shares of Intellia Therapeutics in a research note issued to investors on Monday, May 12th. Cantor Fitzgerald analyst R. Bienkowski now forecasts that the company will post earnings per share of ($3.83) for the year, up from […]
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) – Analysts at Cantor Fitzgerald lifted their FY2025 earnings estimates for shares of Intellia Therapeutics in a research note issued to investors on Monday, May 12th. Cantor Fitzgerald analyst R. Bienkowski now forecasts that the company will post earnings per share of ($3.83) for the year, up from […]
